Truist Financial Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Eli Lilly & Co (LLY – Research Report).
Truist maintains Buy on Amentum stock, reiterates $31 target
Truist Securities sustained its optimistic stance on Amentum Holdings Inc. (NYSE:AMTM) following the company's release of favorable first-quarter 2025 results. With current revenue of $9.82 billion ...
Truist maintains Eli Lilly stock Buy rating, $1038 target
Truist Securities reaffirmed its Buy rating and $1,038.00 price target for Eli Lilly and Company (NYSE:LLY) shares, with analyst targets ranging from $580 to $1,190. The company, which has ...